Treatment of non-small cell lung cancer based on the theory of “lungs as the blood organ”

Yuxiao Gou; Zihan Wang; Yuhan Wei; Shengjun Sun; Meng Dong; Yongqi Kang; Jiansen Chang; Wenjie Chen

doi:10.54254/3049-5458/1/2024003

Research Article

Open access

Published on 29 April 2024

Download pdf

Gou,Y.;Wang,Z.;Wei,Y.;Sun,S.;Dong,M.;Kang,Y.;Chang,J.;Chen,W. (2024). Treatment of non-small cell lung cancer based on the theory of “lungs as the blood organ”. Journal of Clinical Technology and Theory,1,13-18.

Export citation

Treatment of non-small cell lung cancer based on the theory of “lungs as the blood organ”

Yuxiao Gou ¹, Zihan Wang *^,2, Yuhan Wei ³, Shengjun Sun ⁴, Meng Dong ⁵, Yongqi Kang ⁶, Jiansen Chang ⁷, Wenjie Chen ⁸

¹ Shandong University of Traditional Chinese Medicine
² Shandong University of Traditional Chinese Medicine
³ Shandong University of Traditional Chinese Medicine
⁴ Shandong University of Traditional Chinese Medicine
⁵ Shandong University of Traditional Chinese Medicine
⁶ Shandong University of Traditional Chinese Medicine
⁷ Shandong University of Traditional Chinese Medicine
⁸ Shandong University of Traditional Chinese Medicine

* Author to whom correspondence should be addressed.

https://doi.org/10.54254/3049-5458/1/2024003

Abstract

Lung cancer has become one of the most common types of cancer, with high incidence and mortality rates persistently high. Among them, non-small cell lung cancer (NSCLC) is particularly common, accounting for up to 85% of lung cancer cases. NSCLC seriously endangers the health of people in China and around the world, and its specific causes are related to various factors such as smoking, radiation exposure, air pollution, and genetic factors. In traditional Chinese medicine, NSCLC belongs to the category of lung consolidation. Professor Zhang Wei believes that the lungs not only govern the qi of the body, but also play an important role in the generation and circulation of blood throughout the body, and has extensively expounded the viewpoint of “lungs as the blood organ.” This viewpoint is reflected in various functions of the lungs, such as the lungs controlling the hundred vessels, governing the storage of fluids, and controlling the skin and hair. The propulsion of lung qi also provides impetus for the normal circulation of blood. As the lungs serve as the blood organ and are prone to stasis, they are susceptible to the occurrence of “lung consolidation.” Therefore, the occurrence of NSCLC may be related to blood stasis in the lungs. Blood stasis is not only the pathological product of lung consolidation, but also the main cause of lung consolidation. It can be inferred that in the treatment of NSCLC, methods such as promoting blood circulation, dredging collaterals, and resolving phlegm and stasis should be adopted.

Keywords

lungs as the blood organ, non-small cell lung cancer, blood stasis, lung consolidation

View pdf

References

[1]. Wang, J., Xiao, M., Ma, G., et al. (2023). Research progress of traditional Chinese medicine treatment in non-small cell lung cancer. Shaanxi Traditional Chinese Medicine, 44(11), 1663-1665.

[2]. Zhao, L. (2024). Efficacy observation of gefitinib in the treatment of advanced non-small cell lung cancer with targeted therapy. Chinese Journal of Modern Drug Application, 18(04), 82-84. DOI:10.14164/j.cnki.cn11-5581/r.2024.04.022.

[3]. Zhang, W., & Guo, M. (2012). On the theory of “lungs as the source of blood” and promoting blood circulation to remove blood stasis. Jilin Journal of Traditional Chinese Medicine, 32(07), 649-651. DOI:10.13463/j.cnki.jlzyy.2012.07.010.

[4]. Gu, Y., Wang, Y., Qi, A., et al. (2023). Stage-wise rehabilitation treatment strategy of traditional Chinese medicine after surgery for non-small cell lung cancer. Shanghai Journal of Traditional Chinese Medicine, 57(06), 16-19. DOI:10.16305/j.1007-1334.2023.2211037.

[5]. Chen, J., Qiu, L., Wang, L., et al. (2024). Research progress on the potential role of Chinese medicine in the treatment of non-small cell lung cancer. Chinese Traditional Patent Medicine, 46(01), 204-210.

[6]. Zhang, Q., Li, J., & Yao, J. (2023). Research progress of tonifying qi and nourishing yin method in the clinical treatment of advanced non-small cell lung cancer. Journal of Traditional Chinese Medicine and Clinical Research, 35(04), 818-823. DOI:10.16448/j.cjtcm.2023.0439.

[7]. Zhang, B., & Wu, M. (2012). Application of tonifying qi and nourishing yin method in comprehensive treatment of patients with advanced non-small cell lung cancer. Journal of Traditional Chinese Medicine Herald, 18(11), 110-111. DOI:10.13862/j.cnki.cn43-1446/r.2012.11.031.

[8]. Su, S., Lu, X., Huang, Y., et al. (2023). Introduction of Zhou Jihong’s experience in using tonifying the body and fighting cancer method to treat lung cancer. New Chinese Medicine, 55(10), 100-105. DOI:10.13457/j.cnki.jncm.2023.10.021.

[9]. Yu, H. (2023). Research on the system of syndrome differentiation and treatment of hand Taiyin lung meridian diseases in “Lingshu Jingmai” [Master’s thesis, Liaoning University of Traditional Chinese Medicine]. DOI:10.27213/d.cnki.glnzc.2023.000426.

[10]. Chen, X., Ning, Y., Wang, Y., et al. (2024). Experience of famous Chinese medicine practitioner Wang Ruiping in using “nurturing soil to generate gold method” to treat lung cancer. Shaanxi Traditional Chinese Medicine, 45(04), 536-540.

[11]. Jiang, W., Li, Z., Jiang, C., et al. (2021). Molecular mechanism and prognosis analysis of tonifying qi and nourishing yin drugs in the treatment of advanced lung cancer. Chinese Medicine Modern Distance Education, 19(07), 205-208.

[12]. Chen, W., Zhang, N., & Hu, M. (2023). Effects of tonifying qi, nourishing yin, and promoting blood circulation method on vascular neogenesis in rats with idiopathic pulmonary fibrosis. Western Chinese Medicine, 36(09), 14-18.

[13]. Liu, X., & Wu, M. (2023). Experience of Wu Mianhua in the treatment of lung cancer. Chinese Journal of Traditional Chinese Medicine Information on Books and Literature, 47(02), 87-89.

[14]. Jiao, J., Li, Y., Shang, Y., et al. (2021). Efficacy of Qishe Yifei Decoction in assisting the treatment of elderly patients with advanced non-small cell lung cancer and its effects on immune function, serum P53, and Survivin. Sichuan Traditional Chinese Medicine, 39(06), 123-126.

[15]. Wang, X., & Sun, J. (2021). Effect of Ginseng and Astragalus Lung-Enriching Decoction combined with Nivolumab on immune function and quality of life in patients with advanced NSCLC. Journal of Integrated Traditional Chinese and Western Medicine Research, 13(04), 221-225.

[16]. Qiao, X. (2022). Analysis of the efficacy of Spleen-tonifying and Kidney-nourishing Decoction in the adjuvant treatment of advanced non-small cell lung cancer with negative driving gene. Journal of Practical Traditional Chinese Medicine, 38(03), 409-411.

[17]. Wang, J., Lin, Y., Li, H., et al. (2020). Effects of Tonifying Kidney and Lung, Detoxifying Formula combined with chemotherapy on serum Foxp3 and B7-H3 expression in patients with lung and kidney deficiency type advanced non-small cell lung cancer. Journal of Modern Integrated Chinese and Western Medicine, 29(15), 1608-1611.

[18]. Yang, F., Song, L., Fan, R., et al. (2020). Discussion on latent cytomegalovirus pneumonia from the perspective of “lungs as the source of blood”. Chinese Journal of Traditional Chinese Medicine, 35(11), 5446-5448.

[19]. Tian, M., & Zhang, W. (2014). On the theory of “lungs as the source of blood”. Chinese Journal of Traditional Chinese Medicine, 29(03), 680-682.

[20]. Huang, L., & Zhang, W. (2020). Significance of discussing the role of stasis in bronchial asthma from the perspective of “lungs as the source of blood”. Liaoning Journal of Traditional Chinese Medicine, 47(02), 74-75. DOI:10.13192/j.issn.1000-1719.2020.02.022.

[21]. Wang, J., Liu, Y., Pang, L., et al. (2021). Discussion on the efficacy mechanism of idiopathic pulmonary fibrosis based on the theory of “lungs generate blood”. Journal of Traditional Chinese Medicine, 32(12), 2987-2989.

[22]. Zhang, J., Yuan, W., Xia, L., et al. (2023). Discussion on the relationship between chemotherapy-related bone marrow suppression and the theory of “lungs generate blood”. Journal of Modern Integrated Chinese and Western Medicine, 32(15), 2119-2122+2127.

[23]. Borges I, Sena I, Azevedo P, et al. (2017). Lung as a Niche for Hematopoietic Progenitors[J].Stem Cell Reviews and Reports.DOI:10.1007/s12015-017-9747-z.

[24]. Wang, Y., & Zhang, W. (2022). Discussion on the role of collaterals in systemic sclerosis combined with interstitial lung disease based on the theory of “lungs as the source of blood”. World Chinese Medicine, 17(15), 2207-2211.

[25]. Du, X., & Wang, L. (2024). Experience of Wang Lin in the treatment of pediatric cough variant asthma based on the theory of regulating qi. Jiangxi Journal of Traditional Chinese Medicine, 55(02), 42-44. DOI:10.20141/j.0411-9584.2024.02.13.

[26]. Chen, S., Li, X., Zhou, S., et al. (2024). Discussion on the treatment of chest obstruction with Shang Jiongbi Decoction based on the theory of “promoting lung qi descent”. Journal of Integrated Chinese and Western Medicine in Cardio-Cerebrovascular Disease, 22(01), 188-190.

[27]. Li, X., & Song, F. (2022). Discussion on the treatment of paroxysmal atrial fibrillation with traditional Chinese medicine rhythm regulation therapy based on the theory of qi and blood spirit differentiation. Chinese Folk Therapy, 30(21), 17-20. DOI:10.19621/j.cnki.11-3555/r.2022.2106.

[28]. Wen, Y., & Zhang, H. (2022). Summary of Zhang Hong’s experience in treating lung cancer from the perspective of “stasis”. Journal of Traditional Chinese Medicine and Clinical Research, 34(10), 1834-1837. DOI:10.16448/j.cjtcm.2022.1011.

[29]. Jiang, T., Zhu, A., Yang, D., et al. (2021). Interpretation of the pathogenesis of tumor “toxic stasis”. Journal of Zhejiang Chinese Medical University, 45(03), 229-231+239. DOI:10.16466/j.issn1005-5509.2021.03.004.

[30]. Zhang, H., Wang, J., & Zhang, Z. (2012). Clinical efficacy and hemorheological index observation of modified Xuefu Zhuyu Tang in the treatment of blood stasis syndrome in middle and late stage non-small cell lung cancer. Chinese Journal of Clinical Research, 4(14), 8-11.

[31]. Hou, T., You, F., Yan, R., et al. (2015). Analysis of intervention of “Fire Depression” on tumor microenvironment. Sichuan Traditional Chinese Medicine, 33(5), 23-25.

[32]. Cheng, Z., & Shu, Q. (2019). Summary of Professor Shu Qijin’s treatment of lung cancer. Journal of Zhejiang Chinese Medical University, 43(5)

Cite this article

Data availability

The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.

Disclaimer/Publisher's Note

The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

About volume

Journal：Journal of Clinical Technology and Theory

Volume number: Vol.1

ISSN：3049-5458(Print) / 3049-5466(Online)

© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open access policy for details).